Logo

Bafna Pharma Share Price

Bafna Pharma (INR)82.50   (0%)

Exchange ScripsBSE532989NSEBAFNAPHISININE878I01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Bafna Pharma Performance

Market performance
Open price79.6
High84.49
Volumes908
Prev Close82.5
Low79.6
Closing date2025-01-10
Historical performance
1 Year High113.00
3 Year High185.50
5 Year High233.55
1 Year Low73.25
3 Year Low73.25
5 Year Low4.40

Bafna Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
198
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-8.99
Dividend Yield
Dividend Yield
N/A

Bafna Pharma Investment Returns

1 Year
-20.1%
3 Years
-42.1%
5 Years
N/A
10 Years
156.6%

Bafna Pharma Technicals

IndicatorsValueSignal
5-DMA82.23Bullish
10-DMA81.58Bullish
20-DMA81.13Bullish
50-DMA80.68Bullish
100-DMA81.05Bullish
200-DMA84.2Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors72077288738475327360
Government---------------

Bafna Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Other Income3431311
Operating Profit15-127-38-47
Interest12169115
Depreciation33354042
Profit Before Tax-19-183-147-204
Consolidated Net Profit-247-189-167-191
Adjusted EPS-9-8-7-10

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Share Capital24237237187
Total Reserves-66-46143200
Minority Interest1-2-7-6
Total Non-Current Liabilities30298413547
Total Liabilities713119513841783
Capital Work in Progress2---------
Total Assets713119513841783

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Cash Flow from Operating Activities-343-18-70-9
Cash Flow from Investing Activities328154380-54
Cash Flow from Financing Activitie73-138-30663
Net Cash Inflow / Outflow58-23-1
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -8.99.
  • 3Y Stock Price CAGR of the stock is -15.7.
  • The stock has a beta of 0.1.
  • In the last financial year, the company had an EBITDA of ₹15 Million.
  • The company generated revenue of ₹425 Million in the previous financial year.

Bafna Pharma

82.50   (0%)

Investment Amount: ₹ 9840
Current Value: ₹ 8250
Performance: -16.2%
P/L: ₹ -1590
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month